Repositrak, INC Form 4 insider transactions

NYSE
ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock under a pre-arranged 10b5-1 plan to fulfill charitable commitments.
NYSE
ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock for charitable purposes under a Rule 10b5-1 plan.
NYSE
ReposiTrak CEO Randall K. Fields sold a total of 7,500 shares of common stock over three days in August 2025, pursuant to a pre-arranged 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock for charitable commitments through a pre-arranged 10b5-1 trading plan.
NYSE
ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc. CEO Randall K. Fields sold common stock totaling 7,500 shares through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc. CEO and 10% owner Randall K. Fields has filed a Form 4 detailing planned sales of common stock in late July 2025 under a Rule 10b5-1 trading plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock across three transactions in late July 2025, executed under a Rule 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak, Inc. CEO and 10% owner Randall K. Fields reported the sale of 7,500 shares of common stock through a pre-arranged Rule 10b5-1 trading plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc.'s Chief Executive Officer and 10% owner, Randall K. Fields, sold 7,500 shares of common stock in early July 2025 through a Rule 10b5-1 trading plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc. Director Ronald C. Hodge acquired 1,879 shares of common stock as compensation for his board service during the first two quarters of 2025, increasing his direct beneficial ownership to 581,151 shares.
NYSE
ReposiTrak, Inc. Director Robert W. Allen increased his direct beneficial ownership of common stock by receiving shares in lieu of cash compensation for his board service.
NYSE
ReposiTrak, Inc. CEO and 10% owner Randall K. Fields reported the sale of 7,500 shares of common stock through a Rule 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak, Inc. CEO Randall K. Fields reported the sale of 7,500 shares of common stock over three days in June 2025, executed automatically under a Rule 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak, Inc. CEO Randall K. Fields reported the sale of 7,500 shares of common stock over three days in mid-June 2025, totaling approximately $152,310, executed under a Rule 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak, Inc. CEO, Director, and 10% Owner Randall K. Fields reported the sale of 7,500 shares of common stock through a Rule 10b5-1 trading plan established for charitable commitments.
NYSE
ReposiTrak, Inc. CEO, Director, and 10% Owner Randall K. Fields reported the sale of 7,500 shares of common stock in early June 2025, executed through a Rule 10b5-1 trading plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc. CEO and 10% owner Randall K. Fields reported the sale of 7,500 shares of common stock through a Rule 10b5-1 trading plan to fulfill charitable commitments.
NYSE
Randall K. Fields, CEO of ReposiTrak, Inc., sold shares of common stock on May 19 and May 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director Peter Larkin sold 8,000 shares of ReposiTrak, Inc. (TRAK) at an average price of $22.1109 on May 16, 2025.
NYSE
ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on May 12th and 13th, 2025, under a pre-arranged Rule 10b5-1 trading plan to fulfill charitable pledges.
NYSE
ReposiTrak's CEO, Randall K. Fields, sold shares of common stock between May 5th and May 7th, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Randall K. Fields, CEO of ReposiTrak, Inc., sold shares of common stock on April 28 and 29, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Randall K. Fields, CEO of ReposiTrak, Inc., sold shares of common stock on April 21 and 22, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ReposiTrak's CEO, Randall K. Fields, sold shares of common stock on April 14 and 15, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on April 7th and 8th, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ReposiTrak's CEO, Randall K. Fields, sold 7,500 shares of common stock at an average price of $20.1551 to fulfill charitable commitments under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ReposiTrak's CEO, Randall K. Fields, sold 7,500 shares of common stock at an average price of $20.5581 to fulfill charitable commitments under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ReposiTrak's CEO, Randall Fields, executed sales of common stock on March 17 and 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on March 10th and 11th, 2025, under a pre-arranged Rule 10b5-1 trading plan.